Total planned funding: $239,725,446
Allocations
Countries/Regions
| Eswatini | $239,725,446 |
Organizational Types
| Private Contractor | $60,552,898 |
| NGO | $49,735,039 |
| University | $42,847,151 |
| Unknown | $38,281,508 |
| Own Agency | $30,434,184 |
| Host Country Government Agency | $6,743,060 |
| Multi-lateral Agency | $6,406,214 |
| Other USG Agency | $3,906,061 |
| FBO | $742,500 |
| Implementing Agency | $76,831 |
Program Areas
| Care | $73,320,641 |
| Treatment | $57,755,863 |
| Prevention | $42,485,309 |
| Governance and Systems | $35,452,331 |
| Management and Operations | $17,078,356 |
| Testing | $13,632,946 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $41,603,431 |
| HBHC: Care: Adult Care and Support | $28,434,988 |
| HKID: Care: Orphans and Vulnerable Children | $21,228,181 |
| HVSI: Strategic Information | $18,972,938 |
| HVMS: Management and Operations | $17,078,356 |
| HVTB: Care: TB/HIV | $16,453,283 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $14,157,857 |
| HVCT: Testing: HIV Testing and Counseling | $13,632,946 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $11,765,863 |
| OHSS: Health Systems Strengthening | $10,889,714 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $10,454,708 |
| HTXD: Treatment: ARV Drugs | $10,200,349 |
| PDCS: Care: Pediatric Care and Support | $7,204,189 |
| PDTX: Treatment: Pediatric Treatment | $5,952,083 |
| HLAB: Laboratory Infrastructure | $5,589,679 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $5,059,881 |
| HMBL: Biomedical Prevention: Blood Safety | $1,047,000 |
| HMIN: Biomedical Prevention: Injection Safety | $0 |
| IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$38,131,508
Countries/Regions
Columbia University:
$36,866,453
Countries/Regions
Pact, Inc.:
$25,157,046
Countries/Regions
USG Aggregated Agencies:
$17,324,661
Countries/Regions